香港股市 已收市

Sanofi (SAN.PA)

Paris - Paris 延遲價格。貨幣為 EUR。
加入追蹤清單
91.17-0.59 (-0.64%)
收市:05:27PM CET
全螢幕
前收市價91.76
開市91.14
買盤0.00 x 0
賣出價0.00 x 0
今日波幅90.75 - 91.86
52 週波幅80.60 - 105.18
成交量531,333
平均成交量1,323,617
市值113.801B
Beta 值 (5 年,每月)0.44
市盈率 (最近 12 個月)21.20
每股盈利 (最近 12 個月)4.30
業績公佈日2024年4月25日
遠期股息及收益率3.76 (4.10%)
除息日2024年5月13日
1 年預測目標價103.30
  • Insider Monkey

    32 Countries with the Highest Rates of Diabetes

    In this article, we will be taking a look at the 32 countries with the highest rates of diabetes. If you do not want to learn about the global diabetes market, head straight to the 5 Countries with the Highest Rates of Diabetes. The Global Diabetes Market and Its Implications The global diabetes market is […]

  • Insider Monkey

    Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript

    Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript March 21, 2024 Innate Pharma S.A. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: At this time, I would like to welcome everyone to the Innate Pharma Full Year 2023 Financial […]

  • Reuters

    Mirador Therapeutics raises over $400 mln in early funding rounds

    Mirador Therapeutics said on Thursday it had secured more than $400 million to develop precision medicines for immune-related diseases, in a rare, large early-stage fundraise. Easing inflationary pressures, increasing bets of a soft landing and promising data from drug trials are starting to boost the biotech funding market, which saw a downturn last year along with other industries. "This is one of the largest series A rounds, probably in history, certainly this year," Mirador CEO and founder Mark McKenna said, without disclosing the valuation at which the funds were raised or the breakdown of the amounts raised in the latest two rounds.